Prominent Loqtorzi Market Driver for 2025: Rising Prevalence Of Nasopharyngeal Carcinoma And Its Market Implications (2025)

02-18-2025 01:13 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: The Business Research Company

"What Is the Expected Size and Growth Rate of the Loqtorzi Market?
Recent years have seen the loqtorzi market size expand at an $XX. The market is projected to grow from $XX million in 2024 to $XX million in 2025, with a compound annual growth rate (CAGR) of $XX%. This growth witnessed during the historic period is due to factors such as the increment in the number of clinics, a surge in the demand for efficient treatment options, an increase in smoking prevalence, higher investments in health care, and increased adoption of immunotherapy.

In the coming years, the loqtorzi market is projected to experience an FCAGR of $XX %. By 2029, the projected expansion of the market is to reach a value of $XX million, with the compound annual growth rate (CAGR) anticipated to be $XX%. This expected growth during the forecast period stems from factors such as the escalating prevalence of cancer, the increasing understanding and efforts towards its diagnosis and treatment, a growing incidence of nasopharyngeal cancer cases, uptake of combination therapies, and an increased emphasis on early detection and prevention. Key trends for the forecast period include progress in diagnostic methods, breakthroughs in treatment modalities, the development of innovative drug formulations, advancements in radiation therapy techniques, and improvements in precision medicine.

What Factors Are Fueling Growth in the Loqtorzi Market?
Advancements in the loqtorzi market are being driven by a surge in the incidence of nasopharyngeal carcinoma. This type of cancer, which affects the nasopharynx, is closely connected to Epstein-Barr virus infections, stressing the importance of early detection in the course of treatment. The growing incidence of this cancer can be correlated to various factors including increased exposure to the Epstein-Barr virus, genetic factors, environmental causes like tobacco and alcohol use, as well as dietary choices, especially high intake of preserved and salted food. Loqtorzi (toripalimab) offers a new approach to treating nasopharyngeal carcinoma (NPC) patients by fortifying the immune system's capacity to combat cancer cells by stifling the PD-1 pathway. It presents a promising treatment alternative for individuals suffering from recurring or metastatic NPC, deployed either in conjunction with chemotherapy or as a standalone therapy following disease progression. For example, in 2022, the World Cancer Research Fund, a US cancer charity, publicised that over 120,434 fresh cases of nasopharyngeal cancer (NPC) were identified globally. Consequently, the escalating incidence of nasopharyngeal carcinoma is fuelling the expansion of the loqtorzi market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20148&type=smp

Which Leading Companies Are Shaping the Growth of the Loqtorzi Market?
Major companies operating in the loqtorzi market include Coherus BioSciences Inc.; Shanghai Junshi Biosciences Co. Ltd.

What Are the Emerging Trends in the Loqtorzi Industry?
The primary trend affecting the loqtorzi market is the emphasis on creating biosimilars to expand their product range and provide affordable alternatives to biologic therapies. Biosimilars are biological products that bear a high resemblance to an already approved reference product, with no significant disparities in safety or efficacy. They become a more cost-effective solution to expensive biologic drugs once the patent for the original product expires. For instance, Dr. Reddy's Laboratories, a company based in India, released a biosimilar of Loqtorzi (toripalimab) by Coherus BioSciences (CHRS) in India in November 2024 under the name Zytorvi. This medication is used for treating adults suffering from recurrent or metastatic nasopharyngeal carcinoma (RM-NPC), an uncommon cancer type. Loqtorzi received FDA approval in October 2023 as the first-line treatment option for RM-NPC in association with cisplatin and gemcitabine, and as a singular therapy for individuals experiencing disease progression post platinum-based chemotherapy. It remains the only FDA-approved immuno-oncology drug for this particular indication.

What Are the Key Segments of the Loqtorzi Market?
The loqtorzi market covered in this report is segmented -

1) By Formulation: Injectable Formulation (intravenous), Lyophilized Powder For Reconstitution
2) By Indication: Treatment Of Small Cell Lung Cancer (SCLC), Treatment Of Other Solid Tumors
3) By Patient Demographics: Adult Patients, Geriatric Patients, Pediatric Patients
4) By Distribution Channel: Direct Sales, Wholesalers and Distributors, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Oncology Clinics, Specialty Pharmacies, Research Institutions

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/loqtorzi-global-market-report

Which Region Dominates the Loqtorzi Market?
North America was the largest region in the loqtorzi market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the loqtorzi market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The Loqtorzi Global Market Report?

- Market Size Analysis: Analyze the loqtorzi Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the loqtorzi market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall loqtorzi market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the loqtorzi market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20148

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.